To determine whether opioid receptors in sensory neurons are regulated by chronic exposure to opioids, we assessed the binding of various opioid ligands to membranes derived from isolated rat dorsal root ganglia neurons grown in culture. ]diprenorphine binding sites, respectively. Preexposure of neurons to 10 M naloxone for 48 hr up-regulated the receptors by 40%, whereas incubation with 100 nM to 10 M DAMGO for 48 hr resulted in a significant decrease in the B max value of opioid receptors, with a maximum reduction of 70%. The identification of a high level of opioid receptors expressed in isolated sensory neurons and their modulation by opioids demonstrates that cultured sensory neurons are an excellent model with which to study opioid receptor regulation.
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It is well established that intraspinal administration of opioids causes antinociception in both laboratory animals and humans (1, 2) . The terminals of nociceptive sensory neurons that project to the superficial layers of the dorsal spinal cord represent one site that is proposed to mediate opioid analgesia at the level of the cord. Indeed, using various end points to measure the activity of sensory neurons, investigators have shown that opioids reduce the excitability of these cells. Opioids hyperpolarize sensory neurons (3, 4) , reduce calcium entry (4 -6) , and inhibit the release of neurotransmitters from sensory nerve endings in the dorsal horn of the spinal cord (1, 7, 8) .
Recent studies, however, suggest that the actions of opioids on sensory neurons are more complex and not limited to inhibitory effects (9, 10) . Nanomolar concentrations of morphine can prolong the action potential duration of mouse sensory neuronal explants, whereas higher concentrations shorten the duration (9, 11) . In an analogous manner, morphine can increase or decrease the evoked release of peptides from sensory neurons depending on the concentration of the opioid (12) . The cellular mechanisms mediating the opposing actions of opioids on sensory neurons have not been elucidated. One possible explanation for the opposing actions of opioids is that different effects are mediated by different subtypes of receptors. Indeed, receptor-selective excitatory or inhibitory actions have been observed in opioid regulation of neurotransmitter release from rat trigeminal and spinal cord slices (7, 13) . In rat DRG neurons, activation of -or -but not ␦-opioid receptors reduces calcium currents (14, 15) , whereas in mouse sensory neuronal cultures, low concentrations of agonists increase calcium conductance (11) .
The purpose of the current study was to characterize opioid binding on isolated sensory neurons and to determine whether opioid receptors on these cells can be altered by exposure to agonists or antagonists. The use of primary cultures of sensory neurons as a model system has an advantage in that a relative homogeneous population of nondividing neuronal cells is used that are functionally important in mediating opioid-induced antinociception at the level of the spinal cord.
Although studies have been performed on the regulation of opioid receptors in proliferating cell lines (16) and in central nervous system tissue (17, 18) , results are inconsistent between the various preparations. The up-and down-regulation of opioid receptors after chronic administration of opioids has been demonstrated in several cell lines, including NG108 -15 cells (19) , SK-N-SH cells (20) , and SH-SY5Y cells (21) . In various brain regions, the up-regulation of opioid receptors by antagonists has been observed (17, 18) , whereas the effects of chronic exposure to agonist are equivocal. Down-regulation of opioid receptors in brain is observed only after exposure to nonselective agonists (22, 23) , whereas selective opioid agonists produced either no change (24, 25) or an increase in the number of receptors (26) Opioid peptides (DAMGO and DPDPE) were from Peninsula Laboratories (Belmont, CA). Routinely used chemicals were from Sigma Chemical (St. Louis, MO). Cell culture supplies were purchased from GIBCO-Bethesda Research Labs (Grand Island, NY), and nerve growth factor was from Harlan Bioproducts for Science (Indianapolis, IN). All procedures used in these studies were approved by the Animal Care and Use Committee at Indiana University School of Medicine (Indianapolis, IN).
Cell culture. DRG cultures were prepared as previously described (28) . Briefly, ganglia were dissected from E15-E17 rat embryos and placed in sterile calcium-free, magnesium-free modified HBSS at 4°. After all of the ganglia were removed, they were incubated at 37°for 30 min in 3 ml of HBSS containing 250 mg/ml trypsin to dissociate the cells. After the incubation, 1 mg/ml DNase I was added to the solution, the ganglia were centrifuged at 200 ϫ g for 1 min, and the supernatant was aspirated. Ganglia were then resuspended in HBSS containing 2.5 mg/ml trypsin inhibitor. This solution was again centrifuged at 200 ϫ g for 1 min, and the supernatant was removed. The ganglia were washed once with fresh HBSS and then resuspended in Dulbecco's modified Eagle's medium supplemented with 10% (v/v) heat-inactivated fetal bovine serum, 2 mM glutamine, 50 units/ml penicillin and 50 g/ml streptomycin, 50 M 5-fluoro-2-deoxyuridine, 150 M uridine, and 250 ng/ml nerve growth factor. The individual cells were dissociated by mechanical agitation through a fire-polished Pasteur pipette. A small amount of the cell suspension was removed and stained with trypan blue to determine cell viability (which routinely was ϳ90%). Viable cells were counted using a hemocytometer, and ϳ600,000 cells were placed into each 35-mm tissue culture dish, which had been precoated with 0.5 mg/ml rat tail collagen. The cells were maintained at 37°in a 5% CO 2 /95% air atmosphere, and the medium was changed every 2 days. To determine whether opioid receptors in sensory neurons are modulated by chronic exposure to opioids, cells were pre-exposed to various opioids before binding studies. To account for potential variability between culture preparations, each set of experiments was replicated using cells from at least two different harvests. In addition, in each experiment, the control and treated cells are from the same harvest (i.e., one lot of cells obtained on the same day from embryonic rats dissected out of the same mother rat).
Preparation of sensory neuronal membranes. Sensory neuronal cultures were washed three times with phosphate-buffered saline composed of 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , and 1.4 mM KH 2 PO 4 , pH 7.4. After washing, 1.5 ml of buffer was added to each well. The wells were scraped, and the cell suspension was removed. This solution was centrifuged at 2500 ϫ g for 10 min, the supernatant was aspirated, and the cells were resuspended in 1.5 ml of 5 mM Tris⅐HCl, pH 7.4, and incubated on ice for 10 min. The cells were then homogenized using a Dounce glass homogenizer (15 strokes). An equal volume of 0.64 M sucrose was added to the homogenate, and the solution was mixed and centrifuged at 28,000 ϫ g for 30 min. The supernatant was gently aspirated, and the membrane pellet was resuspended in 5 ml of 50 mM Tris⅐HCl, pH 7.4. To remove the residual opioids, the suspension was incubated at 37°for 15 min and then centrifuged at 28,000 ϫ g for 30 min. These procedures were repeated twice, and the pellet was stored at Ϫ80°until it was used in experiments. Routinely, these membrane fractions were stored for Ͻ2 weeks. On the day of binding experiments, the membrane pellet was resuspended in 50 mM Tris⅐HCl, pH 7.4. Protein concentrations were determined according to the method of Bradford (29) , with BSA used as standard. The final concentration of membrane proteins in each reaction tube was 30-50 g/ml.
Ligand binding studies. 3 H]diprenorphine by ϳ50% compared with binding when membranes were incubated with 0.2% BSA in the buffer. The bound tritiumlabeled ligand was separated from free ligand by rapid filtration through Whatman GF/B filters (Westbury, NY) presoaked with 1% polyethylenimine for 1 hr before filtration. Filters were washed three times with 3 ml of ice-cold 50 mM Tris⅐HCl buffer and dried overnight. Dried filters were placed in 10 ml of Ultima Gold scintillation cocktail (Packard Instrument, Meriden, CT), and radioactivity was determined by liquid scintillation counting. Tritium standard was included in every experiment so we could monitor the counting efficiency. In all experiments, nonspecific binding was determined by incubating membranes for 2 hr with the labeled ligand and 10 M naloxone and was subtracted from total binding to obtain specific binding. In all instances, apparent K d and B max values were determined from Scatchard analysis of complete saturation binding data using the LIGAND computer program obtained from Dr. Peter J. Munson (National Institutes of Health, Bethesda, MD).
Statistics. A paired t test was used to compare the effects of 48-hr exposures to 10 M naloxone or 10 M DAMGO on the K d and B max values of opioid binding. Analysis of variance was used for the comparison of the effects of 100 nM to 10 M DAMGO treatment for 5 or 48 hr. If a significant difference was obtained, data were further analyzed using Fisher's Protected LSD post hoc test.
Results

Characterization of [
3 H]diprenorphine binding. To initially determine whether opioid receptors are present on sensory neurons in culture, we examined the equilibrium binding of the nonselective opioid ligand, [ values for K d and B max calculated from five independent experiments (separate cell preparations) were 0.3 Ϯ 0.2 nM and 1300 Ϯ 200 fmol/mg of protein, respectively. Analysis of the Scatchard plots with the use of LIGAND gave a best fit to a single line, suggesting that the binding in these membranes was predominantly to one site.
To confirm that binding of [ 3 H]diprenorphine is on membranes derived from neurons, we plated 10,000 viable cells/ well and grew them in the absence of nerve growth factor and mitotic inhibitors. In this manner, the non-neuronal cells would divide and grow to confluence, whereas the sensory neurons would not be likely to survive without nerve growth factor. Consequently, membranes from these cultures will be largely from non-neuronal cells. In the membrane preparation from these cultures, specific binding of [ 3 H]diprenorphine was not detectable. This suggests that the opioid binding measured in our cultures is localized to neuronal membranes from cells grown in the presence of nerve growth factor.
The high affinity binding of [ 3 H]diprenorphine to membranes of 13-day-old sensory neurons is displaced by naloxone in a concentration-dependent manner. The maximum displacement of 75 Ϯ 2% of the total [ 3 H]diprenorphine binding is observed when membranes are incubated with a naloxone concentration of Ն1 M. This displacement of partial agonist binding by the antagonist strongly supports that diprenorphine binds to opioid receptors in the membranes prepared from sensory neurons.
To determine whether the level of opioid binding increases as a function of time in culture, we measured binding using To quantitatively assess the abundance of various subtypes of opioid receptors in sensory neurons, saturation binding studies were performed using tritium-labeled selective opioid agonists. Scatchard analyses of a representative binding experiment of each opioid (under equilibrium conditions) are shown in Fig. 3 3 H]diprenorphine binding of 2300 Ϯ 100 and 3200 Ϯ 300 fmol/mg of protein for control and naloxone-treated cells, respectively (Fig. 4B) Fig. 3 ), the lack of an effect of naloxone treatment on binding suggests that the predominant up-regulation is occurring at receptors. Down-regulation of opioid receptors in sensory neurons. To determine whether opioid receptors in sensory neurons are down-regulated by selective opioid agonists, we examined the effect on opioid binding of chronic exposure to DAMGO. We chose to study the agonist DAMGO because is the predominant type present in sensory neurons (see Fig.  3 ). As can be seen in Fig. 5A, (Fig. 5B) . The DAMGO-induced receptor down-regulation was due to change in opioid receptor number without any alteration in receptor affinity, because K d values for opioid receptors from control and DAMGO-treated neurons were not significantly different (0.16 Ϯ 0.04 nM for controls and 0.18 Ϯ 0.03 nM for DAMGO-treated cells).
To demonstrate that the effect of DAMGO was selective for opioid receptors, experiments were performed to determine whether pretreatment with naloxone could attenuate DAMGO-induced down-regulation of binding. The treatment of neuronal cultures with 10 M DAMGO and 10 M naloxone for 48 hr completely attenuated the effect of DAMGO alone (Fig. 5B) . The B max value for [ 3 H]diprenorphine binding from three studies using separate preparations of DRG cells was 2587 Ϯ 229 fmol/mg of protein.
To confirm that the reduction of opioid receptors by prolonged exposure to DAMGO is not due to blocking of binding sites by the ligand itself, a portion of the cells were exposed to 10 M DAMGO for 5 min before cell lysis and membrane preparation. The assumption is that any alteration of binding in these cells with 5-min drug treatment is due to the residual ligand in the membrane preparation. Cells exposed to DAMGO for 5 min displayed a similar level of [ 3 H]diprenorphine binding compared with control cells (Fig. 6) . Thus, the amount of residual DAMGO in the membrane preparation Fig. 3 ). Consequently, we treated cells with lower concentrations of this opioid for 48 hr and assessed [ 3 H]diprenorphine binding. As can be seen in Fig. 6A , DAMGO exposure resulted in a concentration-dependent down-regulation of [ 3 H]diprenorphine binding. Treatment with 10 nM DAMGO for 48 hr did not reduce the B max value compared with control, whereas 100 nM DAMGO reduced maximal binding by 25%. Higher concentrations of DAMGO further reduced the opioid binding, reaching a 70% decrease at 10 M, which was the highest concentration tested. Exposure of cultures to 10 M DAMGO for 5 min before membrane preparation did not alter binding compared with control cells, eliminating the possibility that the downregulation was caused by masking of some of the opioid binding sites by residual DAMGO.
To determine whether receptor down-regulation could occur after shorter DAMGO exposure, cells were pretreated with various concentrations of this opioid for 5 hr before opioid binding was measured. As in experiments with 48 hr of DAMGO exposure, 100 nM produced significant downregulation of opioid receptors after a 5-hr exposure to DAMGO (Fig. 6B) . The decrease in binding is also concentration dependent at 5 hr of exposure, when increasing concentrations of DAMGO were tested in three separate experiments. However, the magnitude of reduction with exposure to 1 or 10 M of DAMGO for 5 hr was ϳ40% lower than that obtained with 48-hr exposure at the same concentration. When neurons were exposed to 1 M DAMGO for 24 hr, the B max value was reduced to a similar degree (ϳ50%) as those with 48-hr treatment at the same concentration of DAMGO (data not shown).
Discussion
The results of this study demonstrate that abundant opioid binding sites exist on sensory neurons and that these receptors can be up-and down-regulated by chronic exposure to opioids. Indeed, the high abundance of opioid receptors in these neurons and their modulation by opioids establish sensory neuronal cultures as a model for the study of the regulation of opioid receptors and their potential role in opioidinduced antinociception.
We chose to examine binding using rat DRG neurons grown in culture because this provides a relatively homogeneous population of sensory neurons. Furthermore, opioid actions on sensory neurons may be important in mediation of opioid analgesia. Our cultures contain ϳ5% non-neuronal cells. Consequently, we examined binding on cells grown without nerve growth factor and mitotic inhibitors, thereby diminishing the number of sensory neurons. In this preparation, opioid binding measured by [ 3 H]diprenorphine was not detectable, indicating that opioid receptors are not located on non-neuronal cells. The binding we measure in our neuronal cultures therefore is largely, if not exclusively, on sensory neurons.
Specific binding of opioid ligands to membranes prepared from sensory neurons in culture is saturable and of high affinity and can be displaced by naloxone. In addition, opioid receptors in isolated sensory neurons have similar affinities for selective ligands as those found in central nervous system. These observations confirm that the opioid receptors expressed by cultured sensory neurons have characteristics as opioid receptors in vivo. However, the binding of opioid receptors normalized to milligram of protein is higher in cultured rat sensory neurons than in spinal cord or primary cultures of embryonic brain from the same species (31, 32) . This could be due to the presence of neuronal and nonneuronal cells in brain and spinal cord preparations that do not express opioid receptors. It is also possible that sensory neurons in culture contain higher levels of opioid receptors than do other types of neurons, although the calculated B max values in our preparation could be an overestimation of specific binding secondary to the use of relatively high concentrations of naloxone to identify nonspecific binding.
Our data demonstrate that the receptor is the predominant subtype found in sensory neurons because DAMGO occupies 70% of [ 3 H]diprenorphine binding sites and this binding saturates at 2 nM. This value was obtained by estimating the B max values from Scatchard analyses of three separate experiments. Furthermore, the apparent K d value for DAMGO in these studies is ϳ0.5 nM, which corresponds to the affinity of this opioid for receptors (33) . Consequently, the DAMGO binding measured is selective for receptors. There are significantly fewer ␦ and receptors (5% and 10%, respectively) observed in our sensory neuronal cultures. Indeed, the K i values for displacement of [ 3 H]diprenorphine binding by ␦ and agonists were found to be in the micromolar range. Despite these high values, the K d values for both ␦-and -selective agonists were ϳ2 nM. The wide discrepancy between K i and K d values could result from the fact that most diprenorphine binding occurs at receptors, and the K i values of ␦ and agonists represent, in part, nonspecific displacement at binding sites. In saturation binding studies, however, nanomolar concentrations of receptor-selective agonists are used and thus only high affinity binding is measured at the respective receptor subtypes.
The high binding in isolated sensory neurons is in agreement with immunohistochemical studies in the dorsal spinal cord and DRG (34) . However, the low levels of ␦ receptor binding in our results are not consistent with the high level of ␦ receptor-like immunoreactivity detected by immunostaining experiments using dorsal spinal cord (35) . This inconsistency might be accounted for by the fact that the ligand binding requires that the receptor form the appropriate tertiary structure in the membrane, whereas antibodies bind a specific amino acid sequence that may be independent of ligand binding. It is also possible that the neurons in culture have not fully expressed the ␦ receptors because of culture conditions or because they are derived from embryonic tissues. Further studies are needed to determined the reason for the difference in apparent expression of ␦ receptors in our model compared with the results of Arvidsson et al. (35) .
In a similar manner, the low density of receptors in our cultures contrasts with the previous report by Attali and Vogel (32) , which reported sites of 65-80% of total opioid binding sites in the rat spinal cord/DRG culture. There are a number of possible explanations for this discrepancy. First, cocultures of spinal cord slice and DRG contain various types of neurons, whereas our cultures contain only sensory neurons. Consequently, the receptor binding measured by Attali and Vogel could be localized on spinal cord neurons. It also is possible that the interaction between sensory neurons and their target neurons in spinal cord cocultures could enhance the expression of receptors. Finally, the number of receptors found in the cocultures could be overestimated, because binding was measured using a nonselective tritiated ligand (diprenorphine) in the presence of a high concentration of and ␦ ligands. [ 3 H]Diprenorphine could still bind to either or ␦ sites in this preparation, causing an overestimation of the number of sites.
Chronic treatment with opioid antagonists has been shown to increase the number of opioid receptors in brain, cell lines, and primary culture of mouse SC-DRG explants (18, 36, 37) . 3 H]Diprenorphine binding experiments were performed using sensory neuron membranes prepared from cells that had been grown in culture for 13-15 days and exposed to various concentrations of DAMGO for 5 min and (A) 48 hr or (B) 5 hr and from control cells that had been grown in the absence of DAMGO. B max values are determined as a percentage of maximal binding in control cells using Scatchard analysis. In each experiment, control neurons and neurons treated with different concentrations of DAMGO were obtained from the same harvest. Columns, mean Ϯ standard error for three to eight experiments. u, Binding after neurons were exposed to 10 M DAMGO for 5 min; Ⅺ, binding in membranes exposed to various concentrations of DAMGO for 5 or 48 hr; ‫,ء‬ statistically significant difference ( p Ͻ 0.05) between control and DAMGO-treated neurons using analysis of variance and Fisher's protected LSD.
Opioid Receptors in Sensory Neurons
The increase in opioid binding after chronic administration of naltrexone or naloxone results from increases in the maximum binding capacity rather than from an increase in binding affinity. Our data show that the up-regulation of opioid receptors by the chronic use of naloxone is a direct effect on sensory neurons that results in a change in receptor number rather than altered affinity. Thus, our results in large part agree with the previous findings, despite the use of different experimental systems and procedures.
Our findings that exposure to opioid agonists results in a decrease in binding is the first evidence that opioid receptors in sensory neurons are down-regulated. This down-regulation is selective because chronic exposure to the -selective agonist DAMGO does not alter binding of either [ 3 H]U69,593. Furthermore, when sensory neurons are treated with both DAMGO and naloxone for 48 hr, the DAMGO-induced downregulation is not observed. The observed decrease in the number of binding sites after DAMGO could reflect an alteration in the affinity state of the receptor from high to low. Indeed, Werling et al. (38) showed that chronic infusion of morphine into guinea pigs resulted in a decrease in the number of high affinity binding sites in cerebrocortical membranes. We did not examine whether there was an alteration in low affinity binding after chronic exposure to DAMGO. Our results clearly indicate a significant reduction in high affinity binding after DAMGO treatment and establish the use of isolated sensory neurons for further study of the mechanisms for opioid receptor down-regulation.
In previous studies, down-regulation of opioid receptors is produced only by high doses of nonselective and more potent agonists (etorphine, [D-Ala 2 ,D-Leu 5 ]enkephalin) that are associated with significant mortality (22, 23, 39, 40) . Although studies have attempted to demonstrate the ability of morphine and several -selective agonists (e.g., fentanyl, PL017, sufentanyl, alfentanyl) to down-regulate opioid receptors (26, 41) , the magnitude of reduction is either small or not observed. One possible explanation for the discrepancy between these studies and our results in isolated sensory neurons is that previous studies involve long-term in vivo administration of the lipophilic agonists before binding assays. Thus, it is not possible to eliminate the residual opioids in the membranes prepared from the brain, and this exogenous drug can interfere with opioid binding. For example, when [ 3 H]etorphine was used to measure the residual amount after careful washing procedures, 34.6% of the ligand was still tightly bound to the membrane (22) . Our experimental design circumvented this problem, as indicated by a parallel control in every experiment to affirm that residual DAMGO was eliminated and not interfering with our binding assay. We measure opioid bindings in neurons that were exposed to DAMGO for only 5 min before cell lysis and membrane preparation. If the washing procedures left behind a significant amount of DAMGO, the binding in these cells would be lower than that in control cells without DAMGO treatment. Because no difference was observed between neurons exposed to DAMGO for 5 min and control neurons, residual DAMGO could not affect our measurement of opioid bindings.
Another possible explanation for the difference between our results and those observed in brain tissue is that agonistinduced down-regulation could reflect neuronal development. This seems unlikely because all studies comparing binding in cells pre-exposed to opioids had control cultures at the same stage in development. As such, the potential changes secondary to cell age are minimized.
The mechanism to account for opioid receptor regulation in sensory neurons remains unknown. Further studies are warranted to determine (a) the modulation of various subtypes of opioid receptors by selective ligands and (b) the effect of opioids on neurons with down-regulated opioid receptors. Because sensory neurons in culture express a large amount of opioid receptors and because these receptors are regulated by chronic exposure to opioids, these neuronal cultures represent an excellent model for studies of the mechanism of opioid receptor regulation.
